Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML